134 related articles for article (PubMed ID: 10529538)
1. Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson's disease.
Gentil M; Tournier CL; Pollak P; Benabid AL
Eur Neurol; 1999; 42(3):136-40. PubMed ID: 10529538
[TBL] [Abstract][Full Text] [Related]
2. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
Pinto S; Gentil M; Fraix V; Benabid AL; Pollak P
J Neurol; 2003 Feb; 250(2):179-87. PubMed ID: 12574948
[TBL] [Abstract][Full Text] [Related]
3. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T
J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890
[TBL] [Abstract][Full Text] [Related]
4. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
Krack P; Batir A; Van Blercom N; Chabardes S; Fraix V; Ardouin C; Koudsie A; Limousin PD; Benazzouz A; LeBas JF; Benabid AL; Pollak P
N Engl J Med; 2003 Nov; 349(20):1925-34. PubMed ID: 14614167
[TBL] [Abstract][Full Text] [Related]
5. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease.
Molinuevo JL; Valldeoriola F; Tolosa E; Rumia J; Valls-Sole J; Roldan H; Ferrer E
Arch Neurol; 2000 Jul; 57(7):983-8. PubMed ID: 10891980
[TBL] [Abstract][Full Text] [Related]
6. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
[TBL] [Abstract][Full Text] [Related]
7. Effect of bilateral deep-brain stimulation on oral control of patients with parkinsonism.
Gentil M; Garcia-Ruiz P; Pollak P; Benabid AL
Eur Neurol; 2000; 44(3):147-52. PubMed ID: 11053962
[TBL] [Abstract][Full Text] [Related]
8. Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
Pawlukowska W; Gołąb-Janowska M; Safranow K; Rotter I; Amernik K; Honczarenko K; Nowacki P
Neurol Neurochir Pol; 2015; 49(5):302-6. PubMed ID: 26377981
[TBL] [Abstract][Full Text] [Related]
9. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
[TBL] [Abstract][Full Text] [Related]
10. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
11. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease.
Limousin P; Pollak P; Benazzouz A; Hoffmann D; Broussolle E; Perret JE; Benabid AL
Mov Disord; 1995 Sep; 10(5):672-4. PubMed ID: 8552123
[TBL] [Abstract][Full Text] [Related]
12. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
[TBL] [Abstract][Full Text] [Related]
13. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
Limousin P; Krack P; Pollak P; Benazzouz A; Ardouin C; Hoffmann D; Benabid AL
N Engl J Med; 1998 Oct; 339(16):1105-11. PubMed ID: 9770557
[TBL] [Abstract][Full Text] [Related]
14. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance.
Bejjani BP; Dormont D; Pidoux B; Yelnik J; Damier P; Arnulf I; Bonnet AM; Marsault C; Agid Y; Philippon J; Cornu P
J Neurosurg; 2000 Apr; 92(4):615-25. PubMed ID: 10761650
[TBL] [Abstract][Full Text] [Related]
15. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
[TBL] [Abstract][Full Text] [Related]
16. Effects of Levodopa on Vowel Articulation in Patients with Parkinson's Disease.
Okada Y; Murata M; Toda T
Kobe J Med Sci; 2015 Apr; 61(5):E144-54. PubMed ID: 27363398
[TBL] [Abstract][Full Text] [Related]
17. Effect of bilateral subthalamic nucleus stimulation on parkinsonian gait.
Xie J; Krack P; Benabid AL; Pollak P
J Neurol; 2001 Dec; 248(12):1068-72. PubMed ID: 12013584
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
20. Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation.
Romito LM; Contarino MF; Vanacore N; Bentivoglio AR; Scerrati M; Albanese A
Mov Disord; 2009 Mar; 24(4):557-63. PubMed ID: 19097175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
